KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Receivables (2020 - 2025)

Hims & Hers Health's Receivables history spans 6 years, with the latest figure at $32.1 million for Q4 2025.

  • For Q4 2025, Receivables rose 426.23% year-over-year to $32.1 million; the TTM value through Dec 2025 reached $32.1 million, up 426.23%, while the annual FY2025 figure was $32.1 million, 426.23% up from the prior year.
  • Receivables for Q4 2025 was $32.1 million at Hims & Hers Health, up from $6.1 million in the prior quarter.
  • Across five years, Receivables topped out at $32.1 million in Q4 2025 and bottomed at $3.9 million in Q4 2022.
  • The 5-year median for Receivables is $6.1 million (2024), against an average of $10.6 million.
  • The largest annual shift saw Receivables decreased 8.96% in 2024 before it soared 426.23% in 2025.
  • A 5-year view of Receivables shows it stood at $4.1 million in 2021, then dropped by 4.88% to $3.9 million in 2022, then skyrocketed by 71.79% to $6.7 million in 2023, then fell by 8.96% to $6.1 million in 2024, then skyrocketed by 426.23% to $32.1 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Receivables are $32.1 million (Q4 2025), $6.1 million (Q4 2024), and $6.7 million (Q4 2023).